Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk And/or Relapsed/refractory Neuroblastoma or Other GD2-positive Solid Tumors

计划入组 42 人 · 首次发布于 2017 年 12 月 14 日

A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors

计划入组 15 人 · 首次发布于 2014 年 4 月 9 日

GD2-CAR T Cells for Pediatric Brain Tumours

计划入组 54 人 · 首次发布于 2022 年 3 月 28 日

GD2 CAR T cells

Anti-CEA CAR-T cells(Roger Williams Medical Center)

Mister Car Wash

United States

STEM CELLS ARABIA

Jordan

Novel Anti-Infective Technologies, LLC

Synthetic Control Arms in Hematology: Generative AI Poised to Reshape Cancer Trial Design

GD2-Targeting CAR T Cells Show 66% Response Rate in High-Risk Neuroblastoma Trial

GD2-Directed CAR T-Cell Therapy Shows Promise in Pediatric Brain Cancer with Complete Response in One Patient